Suppr超能文献

新西兰医院手术后和创伤后持续使用阿片类药物和与阿片类药物相关的危害:一项基于人群的队列研究。

Persistent opioid use and opioid-related harm after hospital admissions for surgery and trauma in New Zealand: a population-based cohort study.

机构信息

School of Pharmacy, The University of Auckland Faculty of Medical and Health Sciences, Auckland, New Zealand.

Pharmacy Department, Auckland District Health Board, Auckland, New Zealand.

出版信息

BMJ Open. 2021 Jan 19;11(1):e044493. doi: 10.1136/bmjopen-2020-044493.

Abstract

INTRODUCTION

Opioid use has increased globally for the management of chronic non-cancer-related pain. There are concerns regarding the misuse of opioids leading to persistent opioid use and subsequent hospitalisation and deaths in developed countries. Hospital admissions related to surgery or trauma have been identified as contributing to the increasing opioid use internationally. There are minimal data on persistent opioid use and opioid-related harm in New Zealand (NZ), and how hospital admission for surgery or trauma contributes to this. We aim to describe rates and identify predictors of persistent opioid use among opioid-naïve individuals following hospital discharge for surgery or trauma.

METHODS AND ANALYSIS

This is a population-based, retrospective cohort study using linked data from national health administrative databases for opioid-naïve patients who have had surgery or trauma in NZ between January 2006 and December 2019. Linked data will be used to identify variables of interest including all types of hospital surgeries in NZ, all trauma hospital admissions, opioid dispensing, comorbidities and sociodemographic variables. The primary outcome of this study will be the prevalence of persistent opioid use. Secondary outcomes will include mortality, opioid-related harms and hospitalisation. We will compare the secondary outcomes between persistent and non-persistent opioid user groups. To compute rates, we will divide the total number of outcome events by total follow-up time. Multivariable logistic regression will be used to identify predictors of persistent opioid use. Multivariable Cox regression models will be used to estimate the risk of opioid-related harms and hospitalisation as well as all-cause mortality among the study cohort in a year following hospital discharge for surgery or trauma.

ETHICS AND DISSEMINATION

This study has been approved by the Auckland Health Research Ethics Committee (AHREC- AH1159). Results will be reported in accordance with the Reporting of studies Conducted using Observational Routinely collected health data statement (RECORD).

摘要

简介

在全球范围内,阿片类药物的使用量都在增加,用于治疗慢性非癌症相关疼痛。由于担心阿片类药物的滥用会导致持续使用阿片类药物,并随后在发达国家住院和死亡,人们对此表示关注。国际上已经确定,与手术或创伤相关的住院治疗是导致阿片类药物使用增加的原因之一。在新西兰(NZ),关于持续使用阿片类药物和与阿片类药物相关的危害的数据很少,以及手术或创伤住院治疗如何导致这种情况的发生。我们旨在描述在 NZ 接受手术或创伤治疗后出院的阿片类药物初治个体中持续使用阿片类药物的发生率,并确定其预测因素。

方法和分析

这是一项基于人群的回顾性队列研究,使用来自 NZ 全国健康管理数据库的链接数据,这些数据来自 2006 年 1 月至 2019 年 12 月期间接受手术或创伤治疗的阿片类药物初治患者。链接数据将用于确定感兴趣的变量,包括 NZ 所有类型的医院手术、所有创伤性入院、阿片类药物配给、合并症和社会人口统计学变量。本研究的主要结局是持续使用阿片类药物的发生率。次要结局将包括死亡率、阿片类药物相关危害和住院治疗。我们将比较持续和非持续使用阿片类药物的患者群体之间的次要结局。为了计算发生率,我们将总结局事件数除以总随访时间。多变量逻辑回归将用于确定持续使用阿片类药物的预测因素。多变量 Cox 回归模型将用于估计手术后或创伤后一年研究队列中阿片类药物相关危害和住院治疗以及全因死亡率的风险。

伦理和传播

这项研究已经获得了奥克兰健康研究伦理委员会(AHREC-AH1159)的批准。结果将按照《使用观察性常规收集健康数据进行研究报告的声明》(RECORD)进行报告。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a07/7817825/5b784a126370/bmjopen-2020-044493f01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验